Nektar Therapeutics to Participate in Two Investor Conferences in November
SAN FRANCISCO, Nov. 11, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be participating in two upcoming investor conferences. UBS Global Biopharma Conference Format: Fireside Chat and 1x1 meetings Fireside Chat Date: Tuesday, November...
Covered in this story
Call it yourself
No calls on $NKTR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nektar Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.